Icosapent Ethyl Oral Capsule

DRUG2 trials

Sponsors

University of Leeds, Zhejiang Doer Biologics Co., Ltd.

Conditions

Colon Cancer Liver MetastasisSevere Hypertriglyceridemia

Phase 3

A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia

Not yet recruitingNCT07680829

Zhejiang Doer Biologics Co., Ltd.Severe Hypertriglyceridemia

Start: 2026-08-01End: 2030-10-01Target: 378Updated: 2026-07-06

Unknown Phase

Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases

CompletedNCT04682665

University of LeedsColon Cancer Liver Metastasis

Start: 2021-09-16End: 2024-07-31Updated: 2024-12-04

Related Papers

Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol

BMJ Open2023-11-015 citations